Comparison

RapidAI vs CNS+

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

RapidAI

This application provides AI-driven medical imaging analysis for care teams. It enables rapid, precise management of life-threatening conditions, delivering clinical decision support to accelerate treatment and improve patient outcomes. Physicians receive real-time notifications and can access patient imaging on their mobile devices.

Highlights
  • AI-driven medical imaging analysis
  • Real-time notifications for new cases
  • Access to patient imaging in seconds
  • DICOM viewer with zoom and rotation
  • Organize case results from multiple sites
  • In-app calling for team communication
Features
Read full description

RapidAI is the world leader in AI-driven medical imaging analysis and coordinated care. With the industry’s most validated clinical AI platform, we empower care teams to rapidly, precisely, and confidently manage life-threatening conditions. Trusted by thousands of hospitals in 100+ countries, RapidAI delivers the deepest level of clinical decision support on the market to help accelerate the time to treatment and enhance patient outcomes. We go beyond the algorithm to drive care team collaboration and efficiencies that expand access to life-saving interventions. At RapidAI, we establish new standards for care teams and the patients they treat. Physicians save precious time with anywhere, anytime notifications of new patient cases and access to RapidAI results and patient imaging on their mobile device. Rapid Mobile App Features: - Real-time notifications of new case events and messages - Access to RapidAI results and patient images in as few as 90 seconds of a patient scan - Source file viewing through a powerful DICOM viewer - Full screen zoom functionality and landscape mode - Image rotation for axial, coronal and sagittal views - View and organize case results from multiple sites - Flexible configuration options for PHI, biometrics, Single Sign-on and multi-factor authentication - Centralized views of patient events, messages, and results - Fast notification and coordination of stroke teams for critical cases - Simple entry of key clinical information and ability to upload photos to the message feed - In-app calling for quicker communications with stroke team members RapidAI is not for diagnostic decision making. Refer to the PACS or clinical system for case evaluation.

About

CNS+

Access a comprehensive collection of neurological surgery educational resources, including guidelines, publications, and courses. Manage your professional development with features like 'My Education' and 'My CME'.

Highlights
  • CNS Guidelines access
  • CNS Publications access
  • My Education & My CME integration
  • Case of the Month
  • Neurosurgery Watch
  • Podcasts
  • Courses & Webinars
Features
Read full description

CNS+ houses all the CNS online education and apps you love in one convenient place! Download the app today and access CNS Guidelines, CNS Publications and CNS education in the palm of your hand. CNS+ also integrates with your CNS profile and enables access to "My Education" and "My CME". Features include: - Case of the Month - Neurosurgery Watch - Podcasts - CNS Spotlight - Neurosurgery Surgery Survival Guide - Nexus - Courses - Webinars - And more!

Screenshots

RapidAI4 screens
CNS+4 screens

Verdict

The call

The clearest difference is review sentiment: CNS+ at 100% against RapidAI's 43%. CNS+ also leads on rating (5.0 vs 4.0) and monetization model (free vs ad-supported). RapidAI's advantage is update cadence (every 3 weeks vs every 4 months) and ratings volume (13 vs 4). On price, ads, in-app purchases and device support there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

Both are free to download. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

CNS+ holds the better App Store score, 5.0 against 4.0. Both are backed by a comparable volume of ratings — 13 and 4 respectively. Written reviews point the same way: 43% of RapidAI's written reviews are positive against 100% of CNS+'s.

UpkeepUpdate frequency

RapidAI ships an update every 3 weeks, CNS+ every 4 months. The most recent releases landed on September 25, 2026 and September 22, 2026 respectively.

Scorecard6 real differences · 4 level
RapidAI versus CNS+: the parameters behind the verdict, then further details
ParameterRapidAICNS+
PriceFreeFree
Rating4.0 (13 ratings)5.0 (4 ratings) — better
Positive reviews42.9% of reviews100.0% of reviews — better
Number of ratings13 — better4
Update frequencyEvery 3 weeks — betterEvery 4 months
AdsNoNo
In-app purchasesNoNo
MonetizationAd-supportedFree — better
DevicesiPhone, iPadiPhone, iPad, iPod — better
Requires iOS17.613.0 — better
Further details — not scored
Size135 MB116 MB
Age rating17+17+
DeveloperiSchemaViewCongress of Neurological Surgeons

Customer experience

RapidAI

All ratings13 ratings
Positive69.2%
Neutral7.7%
Negative23.1%
Written reviews7 reviews
Positive42.9%
Neutral14.3%
Negative42.9%

CNS+

All ratings4 ratings
Positive100.0%
Neutral0.0%
Negative0.0%
Written reviews1 reviews
Positive100.0%
Neutral0.0%
Negative0.0%

In-app purchases

None

RapidAI

No in-app purchases

None

CNS+

No in-app purchases

Questions

Is RapidAI free?
RapidAI is free to download, with no in-app purchases.
Is CNS+ free?
CNS+ is free to download, with no in-app purchases.
Which has better reviews, RapidAI or CNS+?
CNS+ is rated higher. RapidAI averages 4.0 out of 5 from 13 ratings, while CNS+ averages 5.0 from 4 ratings.
Do RapidAI or CNS+ have ads?
Neither RapidAI nor CNS+ shows ads.
Which is updated more often, RapidAI or CNS+?
RapidAI ships an update every 3 weeks, and CNS+ every 4 months. Most recently, RapidAI was updated on September 25, 2026 and CNS+ on September 22, 2026.

Other comparisons